Category: Oncology

Statistically Significant Results without the Headache. Q&A with Sarah Church, PhD, Senior Scientist at NanoString.

Talking to Sarah, whether during social gatherings or within the office walls, is always a pleasure. Dr. Church is a Senior Scientist at NanoString, and one of the warmest people you can run into in the hallway. She is also...

/ July 27, 2020

Going Beyond PDL-1. Q&A with Dr. Nina Radosevic- Robin, MD.

Dr. Nina Radosevic-Robin, MD, is a Board-Certified Surgical/Molecular Pathologist at Centre Jean Perrin, a Sr. Scientist within the Unit 1240 of French National Institute for Medical Research (INSERM), and a Lecturer in Molecular Oncology and Protein Science at the University...

/ June 22, 2020

Why is Digital Spatial Profiling Critical to Studying Sarcomas? Q&A with Dr. Troy McEachron, Ph.D

“Whereas the EWS specimens tended to have very simple genomes, the osteosarcoma specimens looked like a hand grenade had gone off in the genome. These were the most fragmented and complex genomes I had ever seen”. Troy McEachron, Ph.D The first...

/ June 15, 2020

Readers’ Favorite Webinars: A Year in Review

NanoString webinars allow you to sit back, relax and listen to a leader in the field talk about his/her research and/or answer your questions.  They have always been a crowd-pleaser, so in 2019 we decided to showcase and summarize them...

/ March 2, 2020

Top 5 Q&A Blog Posts from 2019

Our readers heartily consumed our Q&A blog posts, a series of interviews with scientists from all over the globe who shared with us and our readers the hypotheses behind their research, the challenges encountered, and how they plan to surmount...

/ February 10, 2020